Power Law company profile

CureVac

Biotech & Life Sciences · Tübingen, Germany · Founded 2000 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$599M

Market cap · Jan/2026

Revenue

$589M

Latest reported FY

Investors

10 investors on CureVac's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

DH Capital

Series B+ 9 investors entered at this stage

GSK

Qatar Investment Authority

Baden-Württembergische Versorgungsanstalt für Ärzte

dievini Hopp Biotech holding

Baillie Gifford

University of Tübingen

Bill & Melinda Gates Foundation

KfW

LBBW Venture Capital

Global footprint

Where CureVac has talent and traffic

AI talent share

0.8% of workforce is AI talent
(5 of 640 staff)

Core AI20.31%

Other AI30.47%

Non-AI workforce63599.22%

Web traffic by country

10K monthly visits
across markets

🇦🇺 Australia40%

🇩🇪 Germany36%

🇺🇸 United States16%

🇮🇳 India6%

🇳🇱 Netherlands3%

Top 5 markets shown

Patent intelligence

$159M patent portfolio · 115 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$159M

26.5% of market cap · 4.9× smaller than top peer BioNTech ($780M)

115 active patent families

Where CureVac innovates Molecular biologyRNABioinformaticsIn vitro transcriptionBiochemistry

Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

CureVac on the five Patsnap quality dimensions

CureVac in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where CureVac concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across CureVac and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See CureVac on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo